Résumé
Eurostars is a funding programme for innovative SME leading international project consortia, collaborating with like-minded partners on market-driven research, development and innovation projects and growing their business.
Analyse d'adéquation
Eurostars is a well-established EUREKA programme funding market-driven R&D projects led by innovative SMEs in international consortia, which aligns with Acme Corporation's focus on semiconductors, AI, and deep tech innovation. The programme is technology-agnostic, meaning semiconductor and AI projects are eligible, but there is no sector-specific targeting that makes this a perfect fit. A key eligibility constraint is that the lead applicant must be an SME — if Acme Corporation qualifies as an SME under EU/EUREKA definitions, this is actionable; if it is a large corporation, eligibility is compromised. Switzerland is a Eurostars participating country (via Innosuisse), and Acme's target geographies (France, Germany, Netherlands, etc.) are all Eurostars member states, making consortium formation feasible. The deadline of January 16, 2026 is over eight months away, reducing urgency, but early consortium building is advisable given the complexity of international R&D partnerships.
Verify Acme Corporation's SME status under EUREKA/Eurostars eligibility criteria and check the specific national funding conditions via Innosuisse (for Swiss partners) and the relevant national funding agencies in target countries (e.g., Bpifrance, CDTI, RVO) for the January 2026 cut-off.
Scores détaillés
Brief exécutif
LowPas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.
Description
Eurostars is a funding programme for innovative SME leading international project consortia, collaborating with like-minded partners on market-driven research, development and innovation projects and growing their business.